USANA Health Sciences Inc.
USNA | NYSE
$14.49
+$0.35 (+2.48%)
At close: Sep 21, 2026, 4:00 PM ET
$14.49
$0 (0.00%)
Pre-market:
Sep 22, 2026, 8:26 AM ET
Company Profile
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Key Executives
| Name | Position |
|---|---|
| Kevin G. Guest | CEO & Executive Chairman |
| G. Douglas Hekking | Chief Financial Officer |
| Joshua Foukas | Chief Legal Officer, General Counsel & Corporate Secretary |
| Peter Benedict | Chief Information Officer |
| Walter Noot | Chief Operating Officer |
| Brent L. Neidig | Chief Commercial Officer |
| John Cuomo | Executive Director of Product Development & Technology |
| Kathryn Armstrong | Chief Scientific Officer |
| Myron W. Wentz | Founder & Chairman Emeritus |
| Patrique Richards | Executive Director of Investor Relations & Business Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 13, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 13, 2026 | 10-Q | Quarterly Report |
| Aug 04, 2026 | 8-K | Current Report |
| Jul 27, 2026 | 4 | Filing |
| Jul 27, 2026 | 4 | Filing |
| Jul 27, 2026 | 4 | Filing |
| Jul 27, 2026 | 4 | Filing |
| Jul 27, 2026 | 4 | Filing |
| Jul 27, 2026 | 4 | Filing |
| Jul 27, 2026 | 4 | Filing |
USANA Health Sciences Inc.
| Country | United States |
| IPO Date | Apr 3, 1994 |
| Industry | Household & Personal Products |
| Sector | Consumer Defensive |
| Employees | 1,570 |
| CEO | Kevin G. Guest |
Contact Details
3838 West Parkway Boulevard Salt Lake City,
Utah 84120 United States
Stock Details
| Ticker Symbol | USNA |
| Exchange | NYSE |
| Fiscal Year | February - January |
| Reporting Currency | USD |
| CIK Code | 0000896264 |
| CUSIP Number | 90328M107 |
| ISIN Number | US90328M1071 |
| SIC Code | 2833 |
Add to Watchlist
Select watchlists to add or remove USNA